Update under Regulation 30 read with Para A Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
MEDPLUS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
MedPlus Health Services' subsidiary Optival Health Solutions Private Limited received a 5-day drug license suspension for its store located at Rajendra Nagar, Karnataka. The order was issued by the Assistant Director, Drugs Control Administration, Bangalore Circle-Haveri, and received by the company on April 4, 2025. The suspension was under Rule 65 of the Drugs and Cosmetics Act, 1940 and Drugs and Cosmetics Rules, 1945. The company estimates a potential revenue loss of only around Rs 1.39 lakh from this temporary suspension.
The impact on the company is negligible as it affects only one store for five days with a minimal estimated revenue loss of about Rs 1.39 lakh. This is unlikely to have any material effect on the company's overall operations or stock price.